Harvest Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-78,900
Closed -$1.47M 77
2022
Q1
$1.47M Sell
78,900
-11,100
-12% -$200K 1.29% 25
2021
Q4
$1.93M Buy
+90,000
New +$1.77M 1.13% 19

Other funds holding OCDX

Harvest Management's OCDX Position: Q2 2022 in Review

Harvest Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 78,900 shares — an estimated $1.47M sold.

Harvest Management first reported a position in OCDX in Q4 2021 and held it in 2 quarters. The position peaked at $1.93M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Harvest Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Harvest Management sold 78,900 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $1.47M.
  • Harvest Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 2 quarters.
  • Harvest Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.93M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Harvest Management's 13F filing for Q2 2022, filed 15 Aug 2022.